SGI
REGN icon

Summit Global Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Summit Global Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.68M Sell
7,506
-2,298
-23% -$1.56M 0.26% 48
2026
Q1 		$7.58M Sell
9,804
-18
-0.2% -$13.8K 0.45% 33
2025
Q4 		$7.58M Sell
9,822
-9,801
-50% -$6.66M 0.45% 26
2025
Q3 		$11M Buy
+19,623
New +$11.1M 0.64% 26
2025
Q2 		– Sell
-2,772
Closed -$1.76M – 513
2025
Q1 		$1.76M Sell
2,772
-7,342
-73% -$5.05M 0.13% 97
2024
Q4 		$7.21M Sell
10,114
-1,754
-15% -$1.47M 0.45% 51
2024
Q3 		$12.5M Buy
11,868
+2,195
+23% +$2.44M 0.8% 27
2024
Q2 		$10.2M Sell
9,673
-2,651
-22% -$2.57M 0.69% 33
2024
Q1 		$11.9M Sell
12,324
-3,915
-24% -$3.72M 0.88% 29
2023
Q4 		$14.3M Buy
16,239
+15,931
+5,172% +$13.1M 0.93% 21
2023
Q3 		$254K Buy
308
+8
+3% +$6.29K 0.02% 453
2023
Q2 		$216K Buy
+300
New +$231K 0.01% 499
2021
Q4 		– Sell
-18,835
Closed -$11.4M – 594
2021
Q3 		$11.4M Buy
18,835
+2,535
+16% +$1.57M 0.85% 31
2021
Q2 		$9.09M Buy
16,300
+713
+5% +$361K 0.54% 36
2021
Q1 		$7.38M Buy
15,587
+14,779
+1,829% +$7.2M 0.47% 50
2020
Q4 		$390K Buy
808
+207
+34% +$112K 0.04% 216
2020
Q3 		$336K Buy
+601
New +$364K 0.03% 213

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Summit Global Investments's REGN Position: Q2 2026 in Review

Summit Global Investments reduced its Regeneron Pharmaceuticals (REGN) stake by 23% in Q2 2026, selling an estimated $1.56M and leaving 7,506 shares worth $4.68M. The position accounts for 0.26% of the portfolio, ranked #48.

Summit Global Investments first reported a position in REGN in Q3 2020 and has held it in 17 quarters since. The position peaked at $14.3M in Q4 2023. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Summit Global Investments held 7,506 shares of Regeneron Pharmaceuticals worth $4.68M as of Q2 2026.
  • Summit Global Investments sold 2,298 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.56M.
  • Regeneron Pharmaceuticals made up 0.26% of Summit Global Investments's portfolio in Q2 2026, its #48 holding.
  • Summit Global Investments first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 17 quarters since.
  • Summit Global Investments's Regeneron Pharmaceuticals position peaked at $14.3M in Q4 2023.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.